Breakout Labs: Thiel's Breakout Labs backs Envisagenics

Breakout Labs, founded by billionaire entrepreneur Peter Thiel, has backed Envisagenics as one of its latest four investments. The New York City-based bioinformatics company has created a software platform to help drug makers develop treatments by replacing manual work with machine-learning algorithms. Its technology, SpliceCore, analyzes large amounts of data from patients to discover genes affected by errors in alternative splicing found in cancer and genetic diseases. Envisagenics is a spinout...